Proven Clinical, Operational, and Economic Benefits
Backed by scientific evidence for chronic Inflammatory Bowel Disease (IBD) with measurable outcomes across clinical care, operational efficiency, and economic impacts
Clinicial Benefits
From reactive to proactive monitoring: improve patients’ tolerance to treatment, adherence, and quality of life.
+70%
of early-detected events allow treatment adjustments without an ER visit (1)
80%
of patients feel better supported thanks to remote monitoring (2)
See sources
(1) Data from the SFNGE (French Society of Digestive Endoscopy) and GETAID
(2) Basch JCO 2017, Richards BMJ Open Gastroenterology 2020
Operational Benefits
From fragmented monitoring to seamless organization: simplify daily workflows for care teams and improve care coordination
+30%
medical time saved with structured alerts (1)
- 40%
number of consultation (2)
Fewer
and shorter phone calls
See sources
(1) ANAP 2021 Report on Remote Monitoring in Oncology
(2) Basch et al., JCO 2017; Buisson et al., APT 2021
Economic Benefits
From complex processes to a streamlined approach: improve operational efficiency and optimize resource allocation
Optimized
Ressource allocation
Scalable
Accross care teams and facilities
See sources
(1) Data from the SFNGE (French Society of Digestive Endoscopy) and GETAID
(2) Basch JCO 2017, Richards BMJ Open Gastroenterology 2020
Built for Every Stakeholder in Gastroenterology Care
Addressing everyone involved in the patient journey — from clinicians to patients themselves.
An interface to monitor patients health in real time with comprehensive oversight capabilities
Prepare consultations with structured data summaries
Combine ePRO and calprotectin results to make faster, more informed décisions with visualized insights
Visualize patient health in a single dashboard
Detect clinical events and proactively identify at-risk patients to optimize care delivery.
Detect inflammation signs early through structured symptom questionnaires
Evaluate treatment efficacy with real-time data collected through the platform
Evaluate patient’s global quality of life to provide more comprehensive care
Reduce phone call frequency and duration
Adjust treatment plans based on patient insights on treatment adherence and satisfaction
Provide targeted support to patients showing signs of deterioration
Keep patients engaged and supported from home
Integration of the feacal calprotectine biomarker in the health pathway
Access reported symptoms (ePROs) and quality of life (QLQ-C30)
Integrate patients' SDOH via structured questionnaires
Access personalized, physician-authored content
Follow digital supportive care programs
An interface to monitor patients, teams, and results in real time with comprehensive oversight capabilities.
Follow inclusions, activity and outcomes
Monitor care teams engagementpatients
Unlock the power of real-world data for your facility
Access our Real-World Data Explorer
Leverage structured clinical & real-world datasets
See sources
(1) Data from the SFNGE (French Society of Digestive Endoscopy) and GETAID
(2) Basch JCO 2017, Richards BMJ Open Gastroenterology 2020
(3) ANAP 2021 Report on Remote Monitoring in Oncology
(4) Basch et al., JCO 2017; Buisson et al., APT 2021
We aim to Support multiple Gastroenterology Pathways
We currently support the Inflammatory Bowel Disease (IBD) pathway with specialized monitoring and management solutions, and we are actively developing additional pathways to be launched soon.
GC-102
Ongoing Multicenter Randomized Trial
We are conducting the GC-102 study in order to generate robust evidence on the budgetary, clinical, and organizational impact of the Resilience Gastroenterology remote monitoring solution, and to assess the level of engagement and adherence among both patients and healthcare professionals.
18 centers
involved in the study
116 patients
enrolled & treated forUlcerative colitis or Crohn’s Disease
.png)
.png)
What our Users Say
Real feedback from healthcare professionals and patients using our solutions daily.
90%*
of clinicians see our solution as a game-changer for identifying non-responders
"It seems like an essential tool for the patient, enabling them to better appropriate their disease and their follow-up, and for the HCPs. We see a relational benefit in this tripartite journey and a time saving, at a time of medical shortage and resources in the hospital, which is golden for us."
72%*
of nurses report improved patient communication
"RPM is not just a matter of technology: it’s a whole other way of caring. More proactive for us, as nurses, more human too, and more adapted to the reality of patients with IBD."
96%*
of patients comply with both symptom questionnaires and fecal calprotectin testing
"This application helps in the daily life because it addresses the whole daily life, not just the disease. It allows you to tame this disease and have solutions to adapt your daily life to live with it as best as possible."
*Satisfaction survey conducted by Resilience among caregivers & patients using the solution - December 2024.
